MCRX.F Stock Overview

Designs, develops, manufactures, and commercializes healthcare and security markets products using micro-X proprietary cold cathode X-ray technology in Australia, the United States, Asia-Pacific, Europe, the Middle East, and Africa. More details

MCRX.F fundamental analysis
Snowflake Score
Valuation	2/6
Future Growth	6/6
Past Performance	0/6
Financial Health	6/6
Dividends	0/6

Rewards

Earnings are forecast to grow 68.66% per year

Risk Analysis

Shares are highly illiquid

Does not have a meaningful market cap ($46M)

My Notes

Capture your thoughts, links and company narrative

Micro-X Limited Competitors

NeuroOne Medical Technologies

NasdaqCM:NMTC

US$30.6m

Precision Optics Corporation

NasdaqCM:POCI

US$32.1m

PetVivo Holdings

OTCPK:PETV

US$16.0m

Spectral AI

NasdaqCM:MDAI

US$38.8m

Price History & Performance

Summary of share price highs, lows and changes for Micro-X
Historical stock prices
Current Share Price	AU$0.055
52 Week High	AU$0.11
52 Week Low	AU$0.03
Beta	0.51
1 Month Change	-38.89%
3 Month Change	37.50%
1 Year Change	n/a
3 Year Change	n/a
5 Year Change	n/a
Change since IPO	-31.25%

Recent updates

Shareholder Returns

	MCRX.F	US Medical Equipment	US Market
7D	0%	-0.3%	-0.3%
1Y	n/a	12.4%	20.4%

Return vs Industry: Insufficient data to determine how MCRX.F performed against the US Medical Equipment industry.

Return vs Market: Insufficient data to determine how MCRX.F performed against the US Market.

Price Volatility

Is MCRX.F's price volatile compared to industry and market?
MCRX.F volatility
MCRX.F Average Weekly Movement	n/a
Medical Equipment Industry Average Movement	8.2%
Market Average Movement	6.0%
10% most volatile stocks in US Market	18.5%
10% least volatile stocks in US Market	3.0%

Stable Share Price: MCRX.F's share price has been volatile over the past 3 months compared to the US market.

Volatility Over Time: Insufficient data to determine MCRX.F's volatility change over the past year.

About the Company

Founded	Employees	CEO	Website
2011	n/a	Kingsley Hall	www.micro-x.com

Micro-X Limited designs, develops, manufactures, and commercializes healthcare and security markets products using micro-X proprietary cold cathode X-ray technology in Australia, the United States, Asia-Pacific, Europe, the Middle East, and Africa. The company offers carbon nanotube-based X-ray products, including core X-ray tube and high-voltage generator components. It also provides Rover Plus for full medical performance in a mobile system; Head CT, a standard ambulance or retrieval aircraft for stroke; ARGUS for transforming stand-off imaging; Checkpoints, a modular passenger self-screening checkpoint for airports; and Baggage scanner, a CT baggage scanner for passenger self-screening checkpoints.

Micro-X Limited Fundamentals Summary

How do Micro-X's earnings and revenue compare to its market cap?
MCRX.F fundamental statistics
Market cap	US$28.60m
Earnings (TTM)	-US$6.13m
Revenue (TTM)	US$9.56m

3.0x

P/S Ratio

-4.7x

P/E Ratio

Is MCRX.F overvalued?

See Fair Value and valuation analysis

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
MCRX.F income statement (TTM)
Revenue	AU$15.22m
Cost of Revenue	AU$9.49m
Gross Profit	AU$5.74m
Other Expenses	AU$15.50m
Earnings	-AU$9.76m

Last Reported Earnings

Jun 30, 2024

Next Earnings Date

n/a

Earnings per share (EPS)	-0.017
Gross Margin	37.69%
Net Profit Margin	-64.15%
Debt/Equity Ratio	0%

How did MCRX.F perform over the long term?

See historical performance and comparison

Company Analysis and Financial Data Status

Data	Last Updated (UTC time)
Company Analysis	2025/02/07 10:58
End of Day Share Price	2025/01/17 00:00
Earnings	2024/06/30
Annual Earnings	2024/06/30

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

Package	Data	Timeframe	Example US Source ^*
Company Financials	10 years	Income statement Cash flow statement Balance sheet	SEC Form 10-K SEC Form 10-Q
Analyst Consensus Estimates	+3 years	Forecast financials Analyst price targets	Analyst Research Reports Blue Matrix
Market Prices	30 years	Stock prices Dividends, Splits and Actions	ICE Market Data SEC Form S-1
Ownership	10 years	Top shareholders Insider trading	SEC Form 4 SEC Form 13D
Management	10 years	Leadership team Board of directors	SEC Form 10-K SEC Form DEF 14A
Key Developments	10 years	Company announcements	SEC Form 8-K

^* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

Micro-X Limited is covered by 2 analysts. 1 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

Analyst	Institution
Scott Power	CGS International
Scott Power	Morgans Financial Limited